Last reviewed · How we verify

NCT07032857: IP-ASD

Intestinal Permeability in Children With Autism Spectrum Disorder

Recruiting now Last updated 27 June 2025
What this trial tests

trial in Autism Spectrum Disorders in 55 participants. Currently enrolling.

Timeline
1 January 2023
Primary endpoint
30 September 2025
30 September 2025

Quick facts

Lead sponsorUniversity of Bari
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment55
Start date1 January 2023
Primary completion30 September 2025
Estimated completion30 September 2025
Sites1 location across Italy

Conditions studied

Sponsor

University of Bari

Who can join

Adults 2 to 14, any sex, with Autism Spectrum Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In recent years, increasing attention has been directed toward the role of the gut-brain axis in the pathogenesis of neurodevelopmental disorders, particularly Autism Spectrum Disorder (ASD). Among the multiple contributing factors, the integrity of the intestinal barrier appears to play a crucial role. Enhanced paracellular permeability ("leaky gut") may allow luminal antigens and microbial metabolites to translocate into the systemic circulation, triggering inflammatory responses that could impact neuropsychological functioning. Several studies suggest that, although intestinal permeability is not universally altered in all individuals with ASD, there exists a subset characterized by selective epithelial dysfunction, especially associated with repetitive and stereotyped behaviors. This project aims to investigate, through a controlled sibling-based design, whether intestinal permeability indices are significantly altered in children with ASD and whether such alterations are specifically correlated with behavioral domains assessed through the ADOS instrument.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Autism Spectrum Disorders

Currently open trials in the same condition.

Other University of Bari trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07032857.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing